Literature DB >> 6576613

Psychological reactions in 102 families with a newborn who has a falsely positive screening test for congenital hypothyroidism.

G Bodegård, K Fyrö, A Larsson.   

Abstract

The potential psychological risks of falsely positive test results in neonatal screenings have not been studied previously. 20 000 newborns were screened for congenital hypothyroidism. Of the 144 positive tests, 137 were false. The families of 102 babies with false positives were explored in reference to their (1) initial parental psychic reactions (emotional reactions and abilities for coping) and (2) residual reactions 6 to 12 months later. 78 families initially exhibited strong emotional reactions. Providing information about a positive screening test is therefore an acute strain to the majority. After a period of 6 to 12 months there was in 18 families persistent insecurity regarding the baby's health. These concerns were linked to the family to the screening and the disease screened for. This may impair the parent-child relation and thus, the child's development. Thus a false positive test appear to trigger in the majority a development of a psychic crisis. 12 families seemed however to have been totally untouched by the potential threat of the information. The crisis is effectively solved by most (consideration must be paid to the integrated psychological support given to all). It is not known whether the 18 risk families actually have been iatrogenically hurt or if their worries brought to attention in connection with the screening merely represent habitual psychic maladjustment. Preparation for parenthood and education about screening principles are beneficial and important. This study demonstrates the importance not only of asking how much worry is elicited but also how this worry is being handled (coping ability) in order to provide a fair estimate as to which families are at risk.

Entities:  

Mesh:

Year:  1983        PMID: 6576613     DOI: 10.1111/j.1651-2227.1983.tb09850.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  8 in total

1.  Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states.

Authors:  Patrice K Held; Stuart K Shapira; Cynthia F Hinton; Elizabeth Jones; W Harry Hannon; Jelili Ojodu
Journal:  Mol Genet Metab       Date:  2015-08-12       Impact factor: 4.797

Review 2.  A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening.

Authors:  J Hewlett; S E Waisbren
Journal:  J Inherit Metab Dis       Date:  2006-08-17       Impact factor: 4.982

3.  Factors that influence parents' experiences with results disclosure after newborn screening identifies genetic carrier status for cystic fibrosis or sickle cell hemoglobinopathy.

Authors:  Jenelle L Collins; Alison La Pean; Faith O'Tool; Kerry L Eskra; Sara J Roedl; Audrey Tluczek; Michael H Farrell
Journal:  Patient Educ Couns       Date:  2012-01-11

4.  Finnish national screening for hypothyroidism. Few false positives, early therapy.

Authors:  M Virtanen; J Perheentupa; J Mäenpää; L Pitkänen; J Pikkarainen
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

5.  Screening for congenital hypothyroidism: the first decade.

Authors:  N D Barnes
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

6.  Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test.

Authors:  Audrey Tluczek; Rebecca L Koscik; Peggy Modaff; Darci Pfeil; Michael J Rock; Philip M Farrell; Caroline Lifchez; Mary Ellen Freeman; William Gershan; Christina Zaleski; Bradley Sullivan
Journal:  J Genet Couns       Date:  2006-08       Impact factor: 2.537

7.  Asthma and family interaction.

Authors:  P A Gustafsson; N I Kjellman; J Ludvigsson; M Cederblad
Journal:  Arch Dis Child       Date:  1987-03       Impact factor: 3.791

8.  Psychological effects of false-positive results in expanded newborn screening in China.

Authors:  Wen-Jun Tu; Jian He; Hui Chen; Xiao-Dong Shi; Ying Li
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.